INS and metabolic dysfunction-associated steatotic liver disease: Corroboration between this in silico study along with further in vivo and in vitro studies would help provide a clearer understanding about the effects of modulation of this receptor on insulin sensitivity and resistance, which can be used to develop alternative therapeutic options for NAFLD and diabetes treatment.